Brian Mehling, M.D., a board-certified orthopedic surgeon and CMO of Blue Horizon International (BHI), will deliver his presentation “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic...
from Event - United States - Latest News http://ift.tt/1NS0A9e
via IFTTT
from Event - United States - Latest News http://ift.tt/1NS0A9e
via IFTTT
No comments:
Post a Comment